|
1
|
Kelly LM and Gilliland DG: Genetics of
myeloid leukemias. Annu Rev Genomics Hum Genet. 3:179–198. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferrara F and Del Vecchio L: Acute myeloid
leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical
entity. Haematologica. 87:306–319. 2002.PubMed/NCBI
|
|
3
|
Rao GW and Hu WX: Synthesis, X-ray
crystallographic analysis, and antitumor activity of
1-acyl-3,6-disubstituted phenyl-1,4-dihydro-1,2,4,5-tetrazines.
Bioorg Med Chem Lett. 15:3174–3176. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rao GW and Hu WX: Synthesis, structure
analysis, and antitumor activity of
3,6-disubstituted-1,4-dihydro-1,2,4,5-tetrazine derivatives. Bioorg
Med Chem Lett. 16:3702–3705. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou YL, Hu WX, Lü YP, Qiu LN, Wang WS,
Yang ZY, Liu JD and Rao GW: Effect of ZGDHu-1 on proliferation and
apoptosis of A549 cells in vitro and antitumor activity in vivo.
Yao Xue Xue Bao. 42:26–34. 2007.(In Chinese). PubMed/NCBI
|
|
6
|
Zhou YL, Lü YP, Hu WX, Qiu LN, Wang WS,
Liu JD and Wu JG: ZGDHu-1-inducing apoptosis of SHI-1 leukemia
cells and its molecular mechanism. Zhongguo Shi Yan Xue Ye Xue Za
Zhi. 15:483–489. 2007.(In Chinese). PubMed/NCBI
|
|
7
|
Zhou YL, Chen LC and Lu YP: Inhibition
effects of ZGDHu-1 on proteasome in Kasumi-1 cells. Zhonghua Xue Ye
Xue Za Zhi. 33:61–63. 2012.(In Chinese). PubMed/NCBI
|
|
8
|
Graña X and Reddy EP: Cell cycle control
in mammalian cells: role of cyclins, cyclin dependent kinases
(CDKs), growth suppressor genes and cyclin-dependent kinase
inhibitors (CKIs). Oncogene. 11:211–219. 1995.PubMed/NCBI
|
|
9
|
Murray AW: Recycling the cell cycle:
cyclins revisited. Cell. 116:221–234. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen T, Stephens PA, Middleton FK and
Curtin NJ: Targeting the S and G2 checkpoint to treat cancer. Drug
Discov Today. 17:194–202. 2012. View Article : Google Scholar
|
|
11
|
Wu ZZ, Chien CM, Yang SH, Lin YH, Hu XW,
Lu YJ, Wu MJ and Lin SR: Induction of G2/M phase arrest and
apoptosis by a novel enediyne derivative, THDA, in chronic myeloid
leukemia (K562) cells. Mol Cell Biochem. 292:99–105. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Larizza L, Magnani I and Beghini A: The
Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid
leukemia. Leuk Lymphoma. 46:247–255. 2005. View Article : Google Scholar
|
|
13
|
Boulton S, Anderson A, Swalwell H,
Henderson JR, Manning P and Birch-Machin MA: Implications of using
the fluorescent probes, dihydrorhodamine 123 and
2′,7′-dichlorodihydrofluorescein diacetate, for the detection of
UVA-induced reactive oxygen species. Free Radic Res. 45:139–146.
2011. View Article : Google Scholar
|
|
14
|
Tao Y, Leteur C, Yang C, Zhang P, Castedo
M, Pierré A, Golsteyn RM, Bourhis J, Kroemer G and Deutsch E:
Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects
of p53 and cell cycle checkpoints. Cell Cycle. 8:1196–1205. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tse AN, Rendahl KG, Sheikh T, Cheema H,
Aardalen K, Embry M, Ma S, Moler EJ, Ni ZJ, Lopes de Menezes DE,
Hibner B, Gesner TG and Schwartz GK: CHIR-124, a novel potent
inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I
poisons in vitro and in vivo. Clin Cancer Res. 13:591–602. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Favaloro B, Allocati N, Graziano V, Di
Ilio C and De Laurenzi V: Role of apoptosis in disease. Aging
(Albany NY). 4:330–349. 2012.
|
|
17
|
Koester SK, Roth P, Mikulka WR, Schlossman
SF, Zhang C and Bolton WE: Monitoring early cellular responses in
apoptosis is aided by the mitochondrial membrane protein-specific
monoclonal antibody APO2.7. Cytometry. 29:306–312. 1997. View Article : Google Scholar
|
|
18
|
Chazotte B: Labeling mitochondria with
rhodamine 123. Cold Spring Harb Protoc. 2011.892–894.
2011.PubMed/NCBI
|
|
19
|
Stark GR and Taylor WR: Control of the
G2/M transition. Mol Biotechnol. 32:227–248. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen MS, Ryan CE and Piwnica-Worms H: Chk1
kinase negatively regulates mitotic function of Cdc25A phosphatase
through 14-3-3 binding. Mol Cell Biol. 23:7488–7497. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee CH and Chung JH: The hCds1 (Chk2)-FHA
domain is essential for a chain of phosphorylation events on hCds1
that is induced by ionizing radiation. J Biol Chem.
276:30537–30541. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen CY, Oliner JD, Zhan Q, Fornace AJ Jr,
Vogelstein B and Kastan MB: Interactions between p53 and MDM2 in a
mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA.
91:2684–2688. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Snigdha S, Smith ED, Prieto GA, et al:
Caspase-3 activation as a bifurcation point between plasticity and
cell death. Neurosci Bull. 28:14–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abraham E: NF-kappaB activation. Crit Care
Med. 28:N100–N104. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Halestrap AP, Doran E, Gillespie JP and
O’Toole A: Mitochondria and cell death. Biochem Soc Trans.
28:170–177. 2000.PubMed/NCBI
|
|
26
|
Zhai D, Jin C, Huang Z, Satterthwait AC
and Reed JC: Differential regulation of Bax and Bak by
anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1. J Biol Chem.
283:9580–9586. 2008. View Article : Google Scholar : PubMed/NCBI
|
